IIM
MYGN icon

INTECH Investment Management’s Myriad Genetics MYGN Stock Holding History

INTECH Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Sell
19,275
-4,558
-19% -$20.7K ﹤0.01% 1932
2026
Q1 		$107K Sell
23,833
-204,946
-90% -$1.07M ﹤0.01% 1880
2025
Q4 		$1.41M Buy
228,779
+193,215
+543% +$1.4M 0.01% 937
2025
Q3 		$257K Sell
35,564
-19,537
-35% -$116K ﹤0.01% 1914
2025
Q2 		$293K Sell
55,101
-36,837
-40% -$218K ﹤0.01% 1876
2025
Q1 		$815K Buy
91,938
+5,760
+7% +$69.2K 0.01% 1324
2024
Q4 		$1.18M Buy
86,178
+57,123
+197% +$1.05M 0.01% 1024
2024
Q3 		$796K Buy
29,055
+7,043
+32% +$191K 0.01% 947
2024
Q2 		$538K Buy
+22,012
New +$483K 0.01% 786

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INTECH Investment Management's MYGN Position: Q2 2026 in Review

INTECH Investment Management reduced its Myriad Genetics (MYGN) stake by 19% in Q2 2026, selling an estimated $20.7K and leaving 19,275 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

INTECH Investment Management first reported a position in MYGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.41M in Q4 2025. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • INTECH Investment Management held 19,275 shares of Myriad Genetics worth $110K as of Q2 2026.
  • INTECH Investment Management sold 4,558 Myriad Genetics shares in Q2 2026, an estimated $20.7K.
  • Myriad Genetics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1932 holding.
  • INTECH Investment Management first reported a position in Myriad Genetics in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's Myriad Genetics position peaked at $1.41M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.